The multiple roles of C-type lectin receptors in cancer

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• C-type lectin receptors (CLRs) are key innate immune receptors recognizing diverse ligands, including microbial components.
• CLRs are expressed in various tumor types, but their specific roles in cancer progression and the underlying mechanisms are not fully understood.
• Tumor-associated glycans are recognized by CLRs, influencing cancer cell behavior and immune responses.

Purpose of the Study:

• To review and summarize the multifaceted roles of C-type lectin receptors (CLRs) in cancer.
• To elucidate the mechanisms by which CLRs contribute to carcinogenesis and tumor development.
• To highlight the potential of CLRs as diagnostic markers and therapeutic targets in oncology.

Main Methods:

• Literature review synthesizing existing research on C-type lectin receptors in cancer.
• Analysis of studies investigating CLR expression patterns in different tumor types.
• Examination of the molecular mechanisms linking CLR-glycan interactions to cancer hallmarks like invasion, migration, and metastasis.

Main Results:

• C-type lectin receptors (CLRs) modulate cancer cell invasion, migration, and metastasis through binding to tumor-associated glycans.
• CLR recognition of tumor glycans by antigen-presenting cells can either stimulate anti-tumor immunity or induce immune tolerance.
• Certain CLRs show potential as diagnostic markers for tumor cells, indicating their utility in cancer diagnostics.

Conclusions:

• C-type lectin receptors (CLRs) play complex roles in cancer, influencing tumor progression and the anti-tumor immune response.
• The therapeutic potential of targeting CLRs for cancer treatment is significant, offering new avenues for drug development.
• CLRs represent promising biomarkers for cancer diagnosis and prognostication, warranting further investigation.